Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation.

Frontiers in immunology - 1 Jan 2026

Ran Lin, Lian Zhaoan, Tian Yong, Qin Li, Xiang Yingchun, Yan Xiaohao, Shui Chengyu

Abstract excerpt

Background: Postoperative recurrence risk in cervical cancer remains heterogeneous, and conventional clinicopathological factors may not fully capture the contribution of the immune microenvironment and systemic inflammation. We investigated whether an integrated immune-inflammatory phenotype combining stromal tumor-infiltrating lymphocytes (TILs) and the systemic immune-inflammation index (SII) could improve...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Differentiation, Myelomonocytic
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD163 Antigen

Share to CD8 Antigens

Share to Lymphocytes, Tumor-Infiltrating

Share to Neoplasm Recurrence, Local

Share to Tumor Microenvironment

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42382777
DOI: 10.3389/fimmu.2026.1850891
PMCID: PMC13314612

Genes

CD163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation.PMID 42382777Read ↗

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.Semantic proximity Read ↗

Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapySemantic proximity Read ↗

A riskscore-based nomogram for the prediction of overall survival in cervical squamous cell carcinomaSemantic proximity Read ↗

Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancerSemantic proximity Read ↗

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical CancerSemantic proximity Read ↗

Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer.Semantic proximity Read ↗

Tumor-infiltrating immune cells signature predicts recurrence free survival after complete resection of localized primary gastrointestinal stromal tumorsSemantic proximity Read ↗

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical CancerSemantic proximity Read ↗

Identification of prognosis-related genes in the cervical cancer immune microenvironmentSemantic proximity Read ↗

Prognostic genes in the tumor microenvironment in cervical squamous cell carcinomaSemantic proximity Read ↗

Assessment of ESGO Quality Indicators and Factors Associated with Recurrence Following Surgery for Early-Stage Cervical Cancer: A Retrospective Cohort StudySemantic proximity Read ↗

Six-lncRNA Immune Prognostic Signature for Cervical CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.